Stay updated with breaking news from Managed Care. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A survey study showed major barriers to Janus kinase inhibitor (JAKi) therapy for patients with alopecia areata, especially for non-White patients who face higher rates of being uninsured and struggle more to afford the treatment.
On Wednesday, April 24, at 6 p.m. at the Dietrich Theater in downtown Tunkhannock, John Alunni, Administrator at Wyoming County Human Services, and Cammie Anderson, BA Certified Prevention Specialist Drug
Melatonin showed no benefit for cancer-related fatigue or other symptoms in women with early-stage breast cancer receiving radiotherapy treatment.
The FDA encourages collection and reporting of patient-reported outcomes (PROs) in clinical trials, but a substantial proportion of applications seeking product approval lack these data. Assessment of patient-reported outcomes in clinical trials is on the rise, but they frequently are absent from requests for FDA drug approvals.
At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.